NCT00269594

An Open-Label Study Of Lamictal In Neurotic Excoriation

An Open-Label Study of Lamictal In Neurotic Excoriation

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 25 (actual)
• Sponsor: University of Minnesota · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The goal of the proposed study is to evaluate the efficacy and safety of Lamictal in neurotic excoriation. Twenty subjects with neurotic excoriation will receive 12 weeks of open-label treatment with Lamictal. The hypothesis to be tested is that Lamictal will be effective and well tolerated in patients with neurotic excoriation. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.

Conditions

• Neurotic Disorders
• Obsessive-Compulsive Disorder

Interventions

Type	Name	Description
DRUG	Lamictal (lamotrigine)

Timeline

• Start date: 2006-01-01
• Completion: 2006-09-01
• First posted: 2005-12-23
• Last updated: 2007-04-30

Locations

1 site across 1 country: United States